Vice President, Process Development
Stephen Soltys is the Vice President of Process Development at Kriya Therapeutics. Previously, Mr. Soltys was Director of the Manufacturing Science and Technology (MSAT) labs at AveXis, a Novartis company, where he led a team of upstream, downstream, and analytical scientists. Prior to Avexis, Stephen designed the manufacturing processes for multiple gene therapy companies, including Precision Biosciences and Bamboo Therapeutics (a Pfizer, Inc. subsidiary), and was a process development scientist at the University of North Carolina Gene Therapy Center.
Mr. Soltys received his master’s degree in Molecular Biology from Thomas Jefferson University and his undergraduate degree in Biology from Marietta College.